Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts.
BACKGROUND: In vivo imaging using Annexin A5-based radioligands is a powerful technique for visualizing massive cell death, but has been less successful in monitoring the modest cell death typically seen in solid tumors after chemotherapy. Here we combined dynamic positron emission tomography (PET)...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3411630?pdf=render |
_version_ | 1818501434047463424 |
---|---|
author | Qing Cheng Li Lu Jonas Grafström Maria Hägg Olofsson Jan-Olov Thorell Erik Samén Katarina Johansson Hanna-Stina Ahlzén Sharon Stone-Elander Stig Linder Elias S J Arnér Sel-tag Imaging Project |
author_facet | Qing Cheng Li Lu Jonas Grafström Maria Hägg Olofsson Jan-Olov Thorell Erik Samén Katarina Johansson Hanna-Stina Ahlzén Sharon Stone-Elander Stig Linder Elias S J Arnér Sel-tag Imaging Project |
author_sort | Qing Cheng |
collection | DOAJ |
description | BACKGROUND: In vivo imaging using Annexin A5-based radioligands is a powerful technique for visualizing massive cell death, but has been less successful in monitoring the modest cell death typically seen in solid tumors after chemotherapy. Here we combined dynamic positron emission tomography (PET) imaging using Annexin A5 with a serum-based apoptosis marker, for improved sensitivity and specificity in assessment of chemotherapy-induced cell death in a solid tumor model. METHODOLOGY/PRINCIPAL FINDINGS: Modest cell death was induced by doxorubicin in a mouse xenograft model with human FaDu head and neck cancer cells. PET imaging was based on (11)C-labeled Sel-tagged Annexin A5 ([(11)C]-AnxA5-ST) and a size-matched control. 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]-FDG) was utilized as a tracer of tissue metabolism. Serum biomarkers for cell death were ccK18 and K18 (M30 Apoptosense® and M65). Apoptosis in tissue sections was verified ex vivo for validation. Both PET imaging using [(11)C]-AnxA5-ST and serum ccK18/K18 levels revealed treatment-induced cell death, with ccK18 displaying the highest detection sensitivity. [(18)F]-FDG uptake was not affected by this treatment in this tumor model. [(11)C]-AnxA5-ST gave robust imaging readouts at one hour and its short half-life made it possible to perform paired scans in the same animal in one imaging session. CONCLUSIONS/SIGNIFICANCE: The combined use of dynamic PET with [(11)C]-AnxA5-ST, showing specific increases in tumor binding potential upon therapy, with ccK18/K18 serum measurements, as highly sensitive markers for cell death, enabled effective assessment of modest therapy-induced cell death in this mouse xenograft model of solid human tumors. |
first_indexed | 2024-12-10T20:56:07Z |
format | Article |
id | doaj.art-8db49bc6bca7401aa170c70122fdca1b |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T20:56:07Z |
publishDate | 2012-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-8db49bc6bca7401aa170c70122fdca1b2022-12-22T01:33:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4215110.1371/journal.pone.0042151Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts.Qing ChengLi LuJonas GrafströmMaria Hägg OlofssonJan-Olov ThorellErik SaménKatarina JohanssonHanna-Stina AhlzénSharon Stone-ElanderStig LinderElias S J ArnérSel-tag Imaging ProjectBACKGROUND: In vivo imaging using Annexin A5-based radioligands is a powerful technique for visualizing massive cell death, but has been less successful in monitoring the modest cell death typically seen in solid tumors after chemotherapy. Here we combined dynamic positron emission tomography (PET) imaging using Annexin A5 with a serum-based apoptosis marker, for improved sensitivity and specificity in assessment of chemotherapy-induced cell death in a solid tumor model. METHODOLOGY/PRINCIPAL FINDINGS: Modest cell death was induced by doxorubicin in a mouse xenograft model with human FaDu head and neck cancer cells. PET imaging was based on (11)C-labeled Sel-tagged Annexin A5 ([(11)C]-AnxA5-ST) and a size-matched control. 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]-FDG) was utilized as a tracer of tissue metabolism. Serum biomarkers for cell death were ccK18 and K18 (M30 Apoptosense® and M65). Apoptosis in tissue sections was verified ex vivo for validation. Both PET imaging using [(11)C]-AnxA5-ST and serum ccK18/K18 levels revealed treatment-induced cell death, with ccK18 displaying the highest detection sensitivity. [(18)F]-FDG uptake was not affected by this treatment in this tumor model. [(11)C]-AnxA5-ST gave robust imaging readouts at one hour and its short half-life made it possible to perform paired scans in the same animal in one imaging session. CONCLUSIONS/SIGNIFICANCE: The combined use of dynamic PET with [(11)C]-AnxA5-ST, showing specific increases in tumor binding potential upon therapy, with ccK18/K18 serum measurements, as highly sensitive markers for cell death, enabled effective assessment of modest therapy-induced cell death in this mouse xenograft model of solid human tumors.http://europepmc.org/articles/PMC3411630?pdf=render |
spellingShingle | Qing Cheng Li Lu Jonas Grafström Maria Hägg Olofsson Jan-Olov Thorell Erik Samén Katarina Johansson Hanna-Stina Ahlzén Sharon Stone-Elander Stig Linder Elias S J Arnér Sel-tag Imaging Project Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts. PLoS ONE |
title | Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts. |
title_full | Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts. |
title_fullStr | Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts. |
title_full_unstemmed | Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts. |
title_short | Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts. |
title_sort | combining 11c anxa5 pet imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts |
url | http://europepmc.org/articles/PMC3411630?pdf=render |
work_keys_str_mv | AT qingcheng combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT lilu combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT jonasgrafstrom combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT mariahaggolofsson combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT janolovthorell combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT eriksamen combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT katarinajohansson combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT hannastinaahlzen combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT sharonstoneelander combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT stiglinder combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT eliassjarner combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts AT seltagimagingproject combining11canxa5petimagingwithserumbiomarkersforimproveddetectioninlivemiceofmodestcelldeathinhumansolidtumorxenografts |